These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 3282475)
1. Oncogene expression in adenocarcinomas of the colon and in colon tumor-derived cell lines. Untawale S; Blick M Anticancer Res; 1988; 8(1):1-7. PubMed ID: 3282475 [TBL] [Abstract][Full Text] [Related]
2. The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines. Erisman MD; Scott JK; Watt RA; Astrin SM Oncogene; 1988 Apr; 2(4):367-78. PubMed ID: 3283655 [TBL] [Abstract][Full Text] [Related]
3. Expression of the myc gene family in different stages of human colorectal cancer. Finley GG; Schulz NT; Hill SA; Geiser JR; Pipas JM; Meisler AI Oncogene; 1989 Aug; 4(8):963-71. PubMed ID: 2668847 [TBL] [Abstract][Full Text] [Related]
4. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas. Ishiguro N; Matsui T; Shinagawa M Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930 [TBL] [Abstract][Full Text] [Related]
5. Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression. Greco C; Alvino S; Buglioni S; Assisi D; Lapenta R; Grassi A; Stigliano V; Mottolese M; Casale V Anticancer Res; 2001; 21(5):3185-92. PubMed ID: 11848471 [TBL] [Abstract][Full Text] [Related]
6. Changes in c-myc and c-fos expression in a human tumor cell line following exposure to bifunctional alkylating agents. Futscher BW; Erickson LC Cancer Res; 1990 Jan; 50(1):62-6. PubMed ID: 2104539 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb. Melani C; Rivoltini L; Parmiani G; Calabretta B; Colombo MP Cancer Res; 1991 Jun; 51(11):2897-901. PubMed ID: 2032228 [TBL] [Abstract][Full Text] [Related]
8. Gene expression in melanoma cell lines and cultured melanocytes: correlation between levels of c-src-1, c-myc and p53. Chenevix-Trench G; Martin NG; Ellem KA Oncogene; 1990 Aug; 5(8):1187-93. PubMed ID: 1697409 [TBL] [Abstract][Full Text] [Related]
9. Detection of C-myb genetic alterations and mutant p53 serum protein in patients with benign and malignant colon lesions. Greco C; Gandolfo GM; Mattei F; Gradilone A; Alvino S; Pastore LI; Casale V; Casole P; Grassi A; Cianciulli AM Anticancer Res; 1994; 14(3B):1433-40. PubMed ID: 8067719 [TBL] [Abstract][Full Text] [Related]
10. Myb expression is higher in malignant human colonic carcinoma and premalignant adenomatous polyps than in normal mucosa. Ramsay RG; Thompson MA; Hayman JA; Reid G; Gonda TJ; Whitehead RH Cell Growth Differ; 1992 Oct; 3(10):723-30. PubMed ID: 1445802 [TBL] [Abstract][Full Text] [Related]
11. Elevated c-myc messenger RNA in multiple myeloma cell lines. Fourney R; Palmer M; Ng A; Dietrich K; Belch A; Paterson M; Brox L Dis Markers; 1990; 8(3):117-24. PubMed ID: 1980237 [TBL] [Abstract][Full Text] [Related]
12. Increased expression of the c-myc gene without gene amplification in human lung cancer and colon cancer cell lines. Yoshimoto K; Hirohashi S; Sekiya T Jpn J Cancer Res; 1986 Jun; 77(6):540-5. PubMed ID: 3089986 [TBL] [Abstract][Full Text] [Related]
13. Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue. Yokota J; Yamamoto T; Miyajima N; Toyoshima K; Nomura N; Sakamoto H; Yoshida T; Terada M; Sugimura T Oncogene; 1988 Mar; 2(3):283-7. PubMed ID: 3281095 [TBL] [Abstract][Full Text] [Related]
14. Expression of the L-myc gene is under positive control by short-lived proteins. Saksela K Oncogene; 1987; 1(3):291-6. PubMed ID: 2838780 [TBL] [Abstract][Full Text] [Related]
15. Microsatellite deletions in the c-myb transcriptional attenuator region associated with over-expression in colon tumour cell lines. Thompson MA; Flegg R; Westin EH; Ramsay RG Oncogene; 1997 Apr; 14(14):1715-23. PubMed ID: 9135073 [TBL] [Abstract][Full Text] [Related]
16. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines. Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933 [TBL] [Abstract][Full Text] [Related]
17. Role of the alternating reading frame (P19)-p53 pathway in an in vivo murine colon tumor model. Nambiar PR; Giardina C; Guda K; Aizu W; Raja R; Rosenberg DW Cancer Res; 2002 Jul; 62(13):3667-74. PubMed ID: 12097273 [TBL] [Abstract][Full Text] [Related]
19. Growth-dependent expression of human Mr 53,000 tumor antigen messenger RNA in normal and neoplastic cells. Calabretta B; Kaczmarek L; Selleri L; Torelli G; Ming PM; Ming SC; Mercer WE Cancer Res; 1986 Nov; 46(11):5738-42. PubMed ID: 3019534 [TBL] [Abstract][Full Text] [Related]